Trust Point Inc. RGEN REPLIGEN

Ownership history in Trust Point Inc.  ·  11 quarters on record

AI Ownership Summary

Trust Point Inc. reported REPLIGEN (RGEN) in 11 quarterly 13F filings from 2024 Q1 through 2026 Q2. Peak portfolio weight reached 0.09% in 2024 Q3. The latest visible filing shows RGEN at 0.02% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this RGEN ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Trust Point Inc.'s position in REPLIGEN, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

RGEN was reported at 0.02% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.09% in 2024 Q3

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q1 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Trust Point Inc. held RGEN — position size vs. price
% of Fund (quarterly)    RGEN price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 10 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 REDUCED 1,755 -832 -32.2% 0.02% $239K 2026-07-08 $137.41
2026 Q1 REDUCED 2,587 -93 -3.5% 0.03% $305K 2026-04-15 $131.93
2025 Q4 ADDED 2,680 +54 +2.1% 0.03% $439K 2026-01-13 $167.31
2025 Q3 ADDED 2,626 +253 +10.7% 0.03% $351K 2025-10-10 $145.24
2025 Q2 REDUCED 36.8% -0.2% 2,373 -1,383 -36.8% 0.03% $295K 2025-07-10 $134.00
2025 Q1 REDUCED 35.1% -2.2% 3,756 -2,030 -35.1% 0.04% $478K 2025-04-17 $130.00
2024 Q4 REDUCED 26.7% -11.6% 5,786 -2,107 -26.7% 0.06% $833K 2025-01-24 $165.89
2024 Q3 ADDED 7,893 +359 +4.8% 0.09% $1.2M 2024-10-17 $142.14
2024 Q2 ADDED 7,534 +1,558 +26.1% 0.08% $950K 2024-07-24 $131.39
2024 Q1 ADDED 5,976 +1,717 +40.3% 0.09% $1.1M 2024-04-19 $157.14
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About Trust Point Inc. and RGEN

These are the practical questions this page is built to answer before you even open the full history table.

How long has Trust Point Inc. reported owning RGEN?

Trust Point Inc. reported RGEN across 10 quarterly 13F filings, from 2024 Q1 through 2026 Q2.

What was the largest reported RGEN position in Trust Point Inc.'s portfolio?

The largest reported portfolio weight for RGEN was 0.09% in 2024 Q3.

What is the latest reported RGEN position on this page?

The most recent filing on this page is 2026 Q2, when Trust Point Inc. reported 1,755 shares, equal to 0.02% of portfolio, with an estimated market value of $239K.

What does the chart on this RGEN ownership page compare?

The chart compares Trust Point Inc.'s quarterly RGEN portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Trust Point Inc. time their RGEN position?

Based on 13F filing dates vs. subsequent RGEN price moves, Trust Point Inc. correctly timed 4 out of 10 reported position changes (40%). The annualised alpha on RGEN relative to SPY over the holding period was +139.5%.

← Back to Trust Point Inc. Holdings